Ditchcarbon
  • Contact
  1. Organizations
  2. Boehringer Ingelheim Animal Health USA Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated a month ago

Boehringer Ingelheim Animal Health USA Inc. Sustainability Profile

Company website

Boehringer Ingelheim Animal Health USA Inc., a subsidiary of the global pharmaceutical company Boehringer Ingelheim, is headquartered in the United States and operates extensively across North America. Founded in 1885, the company has established itself as a leader in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a diverse portfolio that includes vaccines, parasiticides, and therapeutics, Boehringer Ingelheim is renowned for its commitment to research and development, which drives the creation of unique products tailored to enhance animal well-being. The company’s dedication to advancing animal health has positioned it among the top players in the market, achieving significant milestones in veterinary medicine and animal care.

DitchCarbon Score

How does Boehringer Ingelheim Animal Health USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Boehringer Ingelheim Animal Health USA Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.

29%

Let us know if this data was useful to you

Boehringer Ingelheim Animal Health USA Inc.'s reported carbon emissions

Inherited from C.H. Boehringer Sohn AG & Co. KG

Boehringer Ingelheim Animal Health USA Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary of Boehringer Ingelheim, any potential climate initiatives or emissions data may be cascaded from the parent organisation. However, no specific information regarding such initiatives or targets has been provided. In the context of the animal health industry, companies are increasingly recognising the importance of sustainability and climate action. While Boehringer Ingelheim Animal Health USA Inc. has not yet disclosed its emissions or reduction strategies, the broader industry trend indicates a growing commitment to addressing climate change and reducing environmental impact.

How Carbon Intensive is Boehringer Ingelheim Animal Health USA Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Boehringer Ingelheim Animal Health USA Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Boehringer Ingelheim Animal Health USA Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Boehringer Ingelheim Animal Health USA Inc. is in US, which has a low grid carbon intensity relative to other regions.

Boehringer Ingelheim Animal Health USA Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Boehringer Ingelheim Animal Health USA Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Boehringer Ingelheim Animal Health USA Inc.'s Emissions with Industry Peers

Pahc

US
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Zoetis

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Merck Animal Health

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Idexx Laboratories

US
•
Pharmaceutical Preparation Manufacturing
Updated about 10 hours ago

Neogen

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Cargill

US
•
Food products nec
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy